Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy

W. P. Vaughan, Judith Karp, P. J. Burke

Research output: Contribution to journalArticle

Abstract

Eleven consecutive patients with acute myelocytic leukemia occurring as a second malignancy were treated with high-dose, timed, sequential chemotherapy. Eight of the patients were felt to have 'secondary' acute leukemia because they had received an alkylating agent or radiation therapy. The other three patients were considered controls. Despite a median age of 65, four of the eight secondary leukemia patients achieved complete remission with this regimen. One of the three control patients also achieved complete remission. This remission rate and duration are comparable to what was achieved with this treatment of 'primary' acute myelocytic leukemia during the same period of time. These results suggest that patients with leukemia occurring after an alkylating agent or radiation therapy are not at especially high risk if treated aggressively.

Original languageEnglish (US)
Pages (from-to)204-207
Number of pages4
JournalJournal of Clinical Oncology
Volume1
Issue number3
StatePublished - 1983

Fingerprint

Alkylating Agents
Acute Myeloid Leukemia
Radiotherapy
Drug Therapy
Neoplasms
Leukemia
Second Primary Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy. / Vaughan, W. P.; Karp, Judith; Burke, P. J.

In: Journal of Clinical Oncology, Vol. 1, No. 3, 1983, p. 204-207.

Research output: Contribution to journalArticle

@article{4417c49d066342daacf2b92996d7af04,
title = "Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy",
abstract = "Eleven consecutive patients with acute myelocytic leukemia occurring as a second malignancy were treated with high-dose, timed, sequential chemotherapy. Eight of the patients were felt to have 'secondary' acute leukemia because they had received an alkylating agent or radiation therapy. The other three patients were considered controls. Despite a median age of 65, four of the eight secondary leukemia patients achieved complete remission with this regimen. One of the three control patients also achieved complete remission. This remission rate and duration are comparable to what was achieved with this treatment of 'primary' acute myelocytic leukemia during the same period of time. These results suggest that patients with leukemia occurring after an alkylating agent or radiation therapy are not at especially high risk if treated aggressively.",
author = "Vaughan, {W. P.} and Judith Karp and Burke, {P. J.}",
year = "1983",
language = "English (US)",
volume = "1",
pages = "204--207",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "3",

}

TY - JOUR

T1 - Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy

AU - Vaughan, W. P.

AU - Karp, Judith

AU - Burke, P. J.

PY - 1983

Y1 - 1983

N2 - Eleven consecutive patients with acute myelocytic leukemia occurring as a second malignancy were treated with high-dose, timed, sequential chemotherapy. Eight of the patients were felt to have 'secondary' acute leukemia because they had received an alkylating agent or radiation therapy. The other three patients were considered controls. Despite a median age of 65, four of the eight secondary leukemia patients achieved complete remission with this regimen. One of the three control patients also achieved complete remission. This remission rate and duration are comparable to what was achieved with this treatment of 'primary' acute myelocytic leukemia during the same period of time. These results suggest that patients with leukemia occurring after an alkylating agent or radiation therapy are not at especially high risk if treated aggressively.

AB - Eleven consecutive patients with acute myelocytic leukemia occurring as a second malignancy were treated with high-dose, timed, sequential chemotherapy. Eight of the patients were felt to have 'secondary' acute leukemia because they had received an alkylating agent or radiation therapy. The other three patients were considered controls. Despite a median age of 65, four of the eight secondary leukemia patients achieved complete remission with this regimen. One of the three control patients also achieved complete remission. This remission rate and duration are comparable to what was achieved with this treatment of 'primary' acute myelocytic leukemia during the same period of time. These results suggest that patients with leukemia occurring after an alkylating agent or radiation therapy are not at especially high risk if treated aggressively.

UR - http://www.scopus.com/inward/record.url?scp=0021084038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021084038&partnerID=8YFLogxK

M3 - Article

C2 - 6366134

AN - SCOPUS:0021084038

VL - 1

SP - 204

EP - 207

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 3

ER -